Package Leaflet: Information for the User
Inpalix 3 mg prolonged-release tablets EFG
paliperidone
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the package leaflet:
Paliperidone contains the active substance paliperidone, which belongs to the class of antipsychotic medications.
Paliperidone is used to treat schizophrenia in adults and adolescents aged 15 years and older.
Schizophrenia is a disorder that causes symptoms such as hearing, seeing, or feeling things that do not exist, having false beliefs, being abnormally suspicious, being withdrawn, having incoherent speech, and a flattening of behavior and emotions. People with this disorder may also feel depressed, anxious, guilty, or tense.
Paliperidone is also used to treat schizoaffective disorder in adults.
Schizoaffective disorder is a mental condition in which the person experiences several of the symptoms of schizophrenia (listed in the previous paragraph) in addition to symptoms of mood disorder (feeling euphoric, sad, agitated, distracted, insomnia, talkativeness, loss of interest in daily activities, excessive or insufficient sleep, excessive or insufficient food intake, and recurring thoughts of suicide).
Paliperidone can help alleviate the symptoms of your illness and prevent them from recurring.
Do not takepaliperidone
Warnings andprecautions
Consult your doctor, pharmacist, or nurse before starting to take paliperidone.
Controlled by a doctor for a possible change from manic symptoms to depressive symptoms.
You should know that these two disorders can be caused by this type of medication.
Caused by other medications.
If you have any of these diseases, please consult your doctor, as it may be necessary to adjust your dose or keep you under observation for a while.
Because it has been rarely observed in patients treated with paliperidone that they have a dangerously low number of a type of white blood cells necessary to fight infections in the blood, your doctor may check your white blood cell count.
Paliperidone may cause you to gain weight. Significant weight gain can negatively affect your health. Your doctor will regularly monitor your weight.
In patients treated with paliperidone, diabetes mellitus or worsening of pre-existing diabetes mellitus has been observed, and your doctor should check for signs of increased blood sugar. In patients with pre-existing diabetes mellitus, blood sugar should be regularly monitored.
During eye surgery for cataracts, the pupil (the black circle in the center of the eye) may not increase in size as needed. Additionally, the iris (the colored part of the eye) may become flaccid during surgery, which can cause eye damage. If you are planning to have eye surgery, make sure to inform your ophthalmologist that you are taking this medication.
Children andadolescents
Paliperidone should not be administered to children and adolescents under 15 years of age for the treatment of schizophrenia.
Paliperidone should not be administered to children and adolescents under 18 years of age for the treatment of schizoaffective disorder.
This is because it is unknown whether paliperidone is safe or effective in this age group.
Othermedicines and paliperidone
Tell your doctor or pharmacist if you are using or have recently used other medications.
Abnormalities in heart function may appear when taking this medication with other medications for controlling heart rhythm or other medications such as antihistamines, antimalarials, or antipsychotics.
Since this medication acts primarily on the brain, it may interfere with other medications (or alcohol) that also act on the brain due to the sum of effects on brain function.
This medication may lower blood pressure, so you should be careful if you take this medication with other medications that also lower blood pressure.
This medication may reduce the effect of medications for Parkinson's disease and restless legs syndrome (e.g., levodopa).
The effects of this medication may be affected if you take medications that influence the speed of intestinal movement (e.g., metoclopramide).
A reduction in the dose of this medication should be considered when administered with valproate.
The use of oral risperidone with this medication is not recommended, as this combination may cause an increase in side effects.
Taking paliperidone withalcohol
You should avoid consuming alcohol during treatment with this medication.
Pregnancy andbreast-feeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before taking this medication.
You should not take this medication during pregnancy unless you have discussed it with your doctor.
The following symptoms may occur in newborn babies of mothers who have been treated with paliperidone in the last trimester of pregnancy (the last three months of pregnancy): tremors, stiffness and/or muscle weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your baby develops any of these symptoms, you should contact your doctor.
You should not breastfeed your child while taking this medication.
Driving and usingmachines
During treatment with this medication, dizziness and vision problems (see section 4, possible side effects) may appear. This should be taken into account when maximum attention is required, for example, when driving or operating machinery.
Warnings about excipients
This medication contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially "sodium-free".
Follow the administration instructions for this medication exactly as indicated by your doctor. If you are unsure, consult your doctor, pharmacist, or nurse.
Use inadults
The recommended dose in adults is 6 mg once daily in the morning. Your doctor may increase or decrease the dose within the dosage range of 3 mg to 12 mg once daily in the case of schizophrenia or 6 mg to 12 mg once daily in the case of schizoaffective disorder, depending on how well the medication works for you.
Use inadolescents
The recommended starting dose for the treatment of schizophrenia in adolescents aged 15 years and older is 3 mg once daily in the morning.
For adolescents who weigh 51 kg or more, the dose may be increased within the range of 6 mg to 12 mg once daily.
For adolescents who weigh less than 51 kg, the dose may be increased to 6 mg once daily.
Your doctor will decide how much to administer. The amount you take depends on how well the medication works for you.
How and when to take paliperidone
This medication should be taken orally, swallowed whole with water or other liquids. It should not be chewed, broken, or crushed.
This medication should be taken in the morning with breakfast or on an empty stomach, but in the same way every day. Do not alternate between taking the medication one day with breakfast and the next day on an empty stomach.
The active substance, paliperidone, dissolves once swallowed, and the tablet coating is eliminated from the body through the feces.
Patients with kidney problems
Your doctor may adjust the dose of this medication according to your renal function.
Elderly
Your doctor may reduce your dose of medication if your renal function is reduced.
If you take more paliperidone than you should
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or go to the nearest hospital immediately, or call the Toxicology Information Service. Phone: 91 562 04 20, indicating the medication and the amount ingested. You may experience drowsiness, fatigue, abnormal body movements, difficulty standing and walking, dizziness due to decreased blood pressure, and changes in heart rhythm.
If you forget to take paliperidone
Do not take a double dose to make up for forgotten doses. If you forget a dose, take the next dose the following day. If you forget two or more doses, contact your doctor.
If you stop taking paliperidone
Do not stop taking this medication, as you will lose its effects. You should not stop taking this medication unless your doctor tells you to, as your symptoms may return.
If you have any further questions about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Report immediately to your doctorif:
Very common: may affect more than 1 in 10 patients
rigidity or muscle tension (making sudden movements) and sometimes a feeling of "freezing" of movement that then restarts. Other signs of parkinsonism include walking slowly, dragging feet, tremors while resting, increased saliva and/or drooling, and loss of facial expressiveness
Common: may affect up to 1 in 10 patients
Uncommon: may affect up to 1 in 100 patients
Paliperidone may increase the levels of a hormone called "prolactin" that is detected in blood tests (which may or may not cause symptoms). When symptoms of increased prolactin appear, they can include: (in men) breast swelling, difficulty having or maintaining erections or other sexual dysfunctions, (in women) breast discomfort, milk secretion from the breasts, loss of menstrual periods or other problems with the menstrual cycle
Discinesia tardía (involuntary spasmodic movements that cannot be controlled in the face, tongue, or other parts of the body). Report to your doctor immediately if you experience rhythmic involuntary movements of the tongue, mouth, or face. Withdrawal of paliperidone may be necessary
Increased GGT (a liver enzyme called gamma-glutamyltransferase) in blood, increased liver enzymes in blood
Incontinence (loss of control) of urine, frequent urination, inability to pass urine, pain when urinating
Swelling of the face, mouth, eyes, or lips, swelling of the body, arms, or legs
Rare: may affect up to 1 in 1,000 patients
Unknown: frequency cannot be estimated from available data
The following adverse effects have appeared with the use of another medicine called risperidone, which is very similar to paliperidone, so it is also expected to appear with paliperidone: sleep-related eating disorder, other types of cerebral vascular problems, and crackling sounds in the lungs. Eye problems may also appear during cataract surgery. During cataract surgery, a condition called intraoperative floppy iris syndrome (IFIS) may occur if you are taking or have taken paliperidone. If you need to undergo cataract surgery, make sure to inform your ophthalmologist if you are taking or have taken this medication.
Additional adverse effects in adolescents
Adolescents generally presented similar adverse effects to those found in adults, except for the following adverse effects that were detected more frequently:
Reporting of adverse effects
If you experience adverse effects, consult your doctor, pharmacist, or nurse, even if they are adverse effects that do not appear in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine
Keep this medicine out of the sight and reach of children.
This medicine does not require any special storage temperature. Keep in the original packaging to protect from moisture.
Do not use this medicine after the expiration date that appears on the blister pack and on the box after CAD. The expiration date is the last day of the month indicated.
Medicines should not be thrown away through the wastewater or the trash. Deposit the packaging and the medicines you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and the medicines you no longer need. This way, you will help protect the environment.
Composition of Inpalix
Appearance of the product and package contents
Prolonged-release tablets, round, biconvex, white to grayish-white in color, and marked with "P3" on one side.
It is presented in aluminum blisters (oPA/Al/PVC)/aluminum, in packages of 28 tablets.
Marketing authorization holder
Kern Pharma, S.L.
Venus, 72 – Pol. Ind. Colón II
08228 Terrassa – Barcelona
Spain
Manufacturer
Krka, d.d., Novo mesto
Šmarješka cesta 6
8501 Novo mesto
Slovenia
Date of the last revision of this leaflet: July 2018.
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of INPALIX 3 mg PROLONGED-RELEASE TABLETS in October, 2025 is around 27.58 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.